Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Unicycive Therapeutics (UNCY) Institutional Ownership

Unicycive Therapeutics logo
$4.63 +0.22 (+4.99%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$4.62 -0.01 (-0.22%)
As of 04:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Unicycive Therapeutics (NASDAQ:UNCY)

Current
Institutional Ownership
Percentage
40.42%
Number of
Institutional Buyers
(last 12 months)
12
Total
Institutional Inflows
(last 12 months)
$192.27M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$132.34M
Get UNCY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Unicycive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

UNCY Institutional Buying and Selling by Quarter

Unicycive Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025Nantahala Capital Management LLC939,202$4.56M0.2%-90.0%7.430%
8/14/2025Acuta Capital Partners LLC62,899$300K0.4%-97.3%0.498%
8/14/2025Vivo Capital LLC1,137,015$5.42M0.6%-90.0%8.995%
8/12/2025 JPMorgan Chase & Co.21,709$104K0.0%+11,698.4%0.172%
8/8/2025 Geode Capital Management LLC58,786$280K0.0%-89.9%0.465%
5/15/2025Nantahala Capital Management LLC9,391,994$5.40M0.2%-9.6%7.786%
5/14/2025 Walleye Capital LLC4,094,256$2.35M0.0%-18.1%3.394%
5/12/2025Vivo Capital LLC11,370,152$6.54M0.9%+14.0%9.426%
5/8/2025 XTX Topco Ltd123,233$71K0.0%-28.1%0.103%
2/17/2025Octagon Capital Advisors LP10,000,000$7.94M1.3%+16.8%9.634%
2/17/2025Alyeska Investment Group L.P.1,750,000$1.39M0.0%-22.2%1.686%
2/17/2025Acuta Capital Partners LLC2,303,000$1.83M1.8%+16.4%2.219%
2/14/2025Nantahala Capital Management LLC10,391,994$8.25M0.4%+268.5%10.012%
2/14/2025 Northern Trust Corp58,181$46K0.0%+142.4%0.056%
2/14/2025Silverarc Capital Management LLC2,486,709$1.98M0.4%-37.8%2.396%
2/14/2025Vivo Capital LLC9,970,152$7.92M0.9%+123.0%9.605%
2/13/2025 XTX Topco Ltd171,463$136K0.0%+142.2%0.165%
2/12/2025 Geode Capital Management LLC524,487$417K0.0%+30.3%0.505%
11/20/2024 Virtu Financial LLC73,975$30K0.0%+566.8%0.071%
11/15/2024 XTX Topco Ltd70,784$29K0.0%N/A0.075%
11/14/2024 Walleye Capital LLC5,000,000$2.04M0.0%N/A5.299%
11/14/2024Acuta Capital Partners LLC1,979,199$807K0.7%N/A2.097%
11/13/2024Great Point Partners LLC8,559,000$3.49M1.0%N/A9.071%
10/16/2024 Bleakley Financial Group LLC80,000$33K0.0%N/A0.085%
8/20/2024Nantahala Capital Management LLC2,820,358$1.41M0.1%-15.4%7.499%
7/12/2024Rosalind Advisors Inc.1,571,200$787K0.6%-16.4%4.178%
5/20/2024 Virtu Financial LLC26,082$36K0.0%N/A0.069%
5/16/2024BVF Inc. IL3,611,601$4.98M0.1%+70.5%9.603%
4/25/2024Rosalind Advisors Inc.1,879,646$2.59M2.4%N/A5.407%
2/15/2024BVF Inc. IL2,118,139$1.84M0.0%-37.9%6.095%
11/15/2023RA Capital Management L.P.3,470,688$2.99M0.1%N/A9.987%
11/8/2023Vivo Capital LLC3,470,152$2.98M0.4%N/A9.986%
8/10/2023 Ground Swell Capital LLC20,001$26K0.1%N/A0.131%
4/26/2023 Oxbow Advisors LLC11,861$25K0.0%N/A0.078%
2/15/2023Nantahala Capital Management LLC647,416$350K0.0%-8.9%4.302%
11/15/2022 Board of Trustees of The Leland Stanford Junior University63,019$37K0.0%-74.5%0.419%
11/10/2022Nantahala Capital Management LLC710,542$419K0.0%-2.6%4.721%
8/15/2022Nantahala Capital Management LLC729,680$606K0.0%+13.9%4.855%
4/22/2022 Truist Financial Corp37,462$48K0.0%N/A0.250%
11/12/2021 Board of Trustees of The Leland Stanford Junior University247,583$700K0.1%N/A1.707%
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)

Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).

Click here for the names of our three top stocks to own this year (no purchase necessary).
11/9/2021BlackRock Inc.11,443$33K0.0%N/A0.079%
10/28/2021 Tandem Capital Management Corp ADV15,500$44K0.0%N/A0.107%
(Data available from 1/1/2016 forward)

UNCY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of UNCY shares?

During the previous two years, 17 institutional investors and hedge funds held shares of Unicycive Therapeutics. The most heavily invested institutionals were Octagon Capital Advisors LP ($7.94M), Vivo Capital LLC ($5.42M), BVF Inc. IL ($4.98M), Nantahala Capital Management LLC ($4.56M), Great Point Partners LLC ($3.49M), RA Capital Management L.P. ($2.99M), and Walleye Capital LLC ($2.35M).Learn more on Unicycive Therapeutics' institutional investors.

What percentage of Unicycive Therapeutics' stock is owned by institutional investors?

40.42% of Unicycive Therapeutics' stock is owned by institutional investors. Learn more on UNCY's institutional investor holdings.

Which institutional investors have been buying Unicycive Therapeutics' stock?

Of the 15 institutional investors that purchased Unicycive Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($10.37M), Great Point Partners LLC ($8.56M), Nantahala Capital Management LLC ($7.57M), Walleye Capital LLC ($5M), RA Capital Management L.P. ($3.47M), Acuta Capital Partners LLC ($2.30M), and Rosalind Advisors Inc. ($1.88M).

How much institutional buying is happening at Unicycive Therapeutics?

Institutional investors have bought a total of 32,266,777 shares in the last 24 months. This purchase volume represents approximately $192.27M in transactions.

Which of Unicycive Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Unicycive Therapeutics stock in the last 24 months: Vivo Capital LLC ($10.23M), Nantahala Capital Management LLC ($9.97M), Acuta Capital Partners LLC ($2.29M), Silverarc Capital Management LLC ($1.51M), Walleye Capital LLC ($905.74K), Geode Capital Management LLC ($520.42K), and Alyeska Investment Group L.P. ($500K).

How much institutional selling is happening at Unicycive Therapeutics?

Institutional investors have sold a total of 25,978,826 shares in the last 24 months. This volume of shares sold represents approximately $132.34M in transactions.


Related Companies

This page (NASDAQ:UNCY) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored